Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone ER Maintenance in Bipolar I Disorder
NCT00490971Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- May 2006
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of paliperidone in bipolar I disorder, sponsored by Johnson & Johnson. Started May 2006; status: completed.
02
Drugs
paliperidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00490971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00490971.